Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 2, 2011, Pages 483-491

  Moureau Zabotto, Laurence ^a   Farnault, Bertrand ^a   De Chaisemartin, Cecile ^a   Esterni, Benjamin ^a   Lelong, Bernard ^a   Viret, Frederic ^a   Giovannini, Marc ^a   Monges, Genevieve ^a   Delpero, Jean Robert ^a   Bories, Erwan ^a   Turrini, Olivier ^a   Viens, Patrice ^a   Salem, Naji ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Neoadjuvant chemoradiation; Predictive factors; Rectal cancer; Tumor response

Indexed keywords

5-FLUOROURACIL (5-FU); CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CHEMORADIATION; COMPLETE RESPONSE; DISEASE FREE SURVIVAL; ENDORECTAL ULTRASOUND; MULTI VARIATE ANALYSIS; NEOADJUVANT CHEMORADIATION; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PRE-TREATMENT; PREDICTIVE FACTORS; PREOPERATIVE CHEMORADIATION; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECTAL ADENOCARCINOMA; RECTAL CANCER; SMALL TUMORS; TUMOR RESPONSE;

CHEMOTHERAPY; DISEASES; MULTIVARIANT ANALYSIS; PATHOLOGY; POPULATION STATISTICS;

TUMORS;

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOEMBRYONIC ANTIGEN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955601717     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.02.025     Document Type: Article

References (60)

1. R.J. Heald, E.M. Husband, and R.D. Ryall The mesorectum in rectal cancer surgery: The clue to pelvic recurrence? Br J Surg 69 1982 613 616 (Pubitemid 12038080)
2. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
3. J.F. Bosset, G. Calais, and L. Mineur Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921 J Clin Oncol 23 2005 5620 5627
4. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123 (Pubitemid 44394918)
5. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15 24 (Pubitemid 38952855)
6. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4625 (Pubitemid 46630960)
7. P. Das, J.M. Skibber, and M.A. Rodriguez-Bigas Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Cancer 109 2007 1750 1755 (Pubitemid 46668536)
8. Y.A. Park, S.K. Sohn, and J. Seong Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer J Surg Oncol 93 2006 145 150 (Pubitemid 43235261)
9. H.C. Park, N.A. Janjan, and T.R. Mendoza Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer Int J Radiat Oncol Biol Phys 75 2009 775 781
10. G. Theodoropoulos, W.E. Wise, and A. Padmanabhan T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival Dis Colon Rectum 45 2002 895 903 (Pubitemid 34761469)
11. S.M. Yoon, D.Y. Kim, and T.H. Kim Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 69 2007 1167 1172 (Pubitemid 47625840)
12. A. Habr-Gama Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy Colorectal Dis 8 Suppl 3 2006 21 24
13. American Joint Committee on Cancer AJCC cancer staging manual 6th ed. 2002 Springer New York p. 157-164
14. P. Quirke, P. Durdey, M.F. Dixon, and N.S. Williams Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 2 1986 996 999 (Pubitemid 16005611)
15. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
16. R.D. Madoff Rectal cancer: Optimum treatment leads to optimum results Lancet 373 2009 790 792
17. R.K. Wong, V. Tandan, S. De Silva, and A. Figueredo Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma Cochrane Database Syst Rev 2007 CD002102
18. W. Ceelen, K. Fierens, Y. Van Nieuwenhove, and P. Pattyn Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: A systematic review and meta-analysis Int J Cancer 124 2009 2966 2972
19. D. Sebag-Montefiore, R.J. Stephens, and R. Steele Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicenter, randomised trial Lancet 373 2009 811 820
20. A. Ciccocioppo, J.H. Stephens, P.J. Hewett, and N.A. Rieger Complete pathologic response after preoperative rectal cancer chemoradiotherapy ANZ J Surg 79 2009 481 484
21. S.K. Chennupati, A. Kamaya, and G.A. Fisher Pathological response after chemoradiation for T3 rectal cancer Colorectal Dis 2009 [Epub ahead of print]
22. C. Berger, A. de Muret, and P. Garaud Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications Int J Radiat Oncol Biol Phys 37 1997 619 627 (Pubitemid 27175318)
23. S. Supiot, J. Bennouna, and E. Rio Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer Colorectal Dis 8 2006 430 435 (Pubitemid 43676659)
24. A.S. Dhadda, A.M. Zaitoun, and E.M. Bessell Regression of rectal cancer with radiotherapy with or without concurrent capecitabine: Optimising the timing of surgical resection Clin Oncol (R Coll Radiol) 21 2009 23 31
25. F.M. Vecchio, V. Valentini, and B.D. Minsky The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760 (Pubitemid 40779765)
26. D. Beddy, J.M. Hyland, and D.C. Winter A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy Ann Surg Oncol 15 2008 3471 3477
27. E. Benzoni, D. Intersimone, and G. Terrosu Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer J Clin Pathol 59 2006 505 512
28. M. Gavioli, G. Luppi, and L. Losi Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer Dis Colon Rectum 48 2005 1851 1857 (Pubitemid 41437667)
29. C. Rodel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696 (Pubitemid 46211512)
30. N.A. Janjan, C. Crane, and B.W. Feig Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer Am J Clin Oncol 24 2001 107 112 (Pubitemid 32323343)
31. J.P. Gerard, O. Chapet, A. Ramaioli, and P. Romestaing Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone Int J Radiat Oncol Biol Phys 54 2002 142 149
32. L.J. Kuo, M.C. Liu, and J.J. Jian Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14 2007 2766 2772 (Pubitemid 47460637)
33. J.G. Guillem, D.B. Chessin, and A.M. Cohen Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 2005 829 836 discussion 836-828
34. A.Y. Lin, W.D. Wong, and J. Shia Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy Int J Colorectal Dis 23 2008 243 249
35. T. Suzuki, S. Sadahiro, and M. Fukasawa Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer Jpn J Clin Oncol 34 2004 740 746 (Pubitemid 41615271)
36. E. Benzoni, F. Cerato, and A. Cojutti The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer Tumori 91 2005 401 405 (Pubitemid 41719694)
37. K. Horisberger, A. Treschl, and S. Mai Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: Results of a Phase II MARGIT trial Int J Radiat Oncol Biol Phys 74 2009 1487 1493
38. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674 (Pubitemid 34626505)
39. J. Garcia-Aguilar, J. Pollack, and S.H. Lee Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors Dis Colon Rectum 45 2002 10 15 (Pubitemid 34072746)
40. V. Moreno Garcia, P. Cejas, and M. Blanco Codesido Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy Int J Colorectal Dis 24 2009 741 748
41. R.O. Perez, G.P. Sao Juliao, and A. Habr-Gama The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer Dis Colon Rectum 52 2009 1137 1143
42. C.G. Willett, G. Warland, J. Coen, P.C. Shellito, and C.C. Compton Rectal cancer: The influence of tumor proliferation on response to preoperative irradiation Int J Radiat Oncol Biol Phys 32 1995 57 61
43. C.H. Crane, and D.J. Sargent Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: How much data do we need? J Clin Oncol 22 2004 2978 2981 (Pubitemid 41103708)
44. C.H. Crane, C. Eng, and B.W. Feig Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer Int J Radiat Oncol Biol Phys 76 2009 824 830
45. M.G. Zampino, E. Magni, and M.C. Leonardi Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 75 2009 421 427
46. J. Dunst, J. Debus, and V. Rudat Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial Strahlenther Onkol 184 2008 450 456
47. M. Miwa, M. Ura, M. Nishida, N. Sawada, T. Ishikawa, and K. Mori Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1998 1274 1281 (Pubitemid 28342121)
48. A. Debucquoy, L. Goethals, and L. Libbrecht Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study Int J Colorectal Dis 24 2009 129 138
49. A. Debucquoy, K. Haustermans, and A. Daemen Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer J Clin Oncol 27 2009 2751 2757
50. I. Zlobec, R. Steele, and C.C. Compton VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy Cancer 104 2005 2517 2521 (Pubitemid 41691576)
51. I. Zlobec, T. Vuong, and C.C. Compton Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy Br J Cancer 98 2008 450 456 (Pubitemid 351161259)
52. J.P. Machiels, C. Sempoux, and P. Scalliet Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer Ann Oncol 18 2007 738 744 (Pubitemid 46523279)
53. C. Rodel, D. Arnold, and M. Hipp Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer Int J Radiat Oncol Biol Phys 70 2008 1081 1086 (Pubitemid 351296110)
54. E. Lopez-Crapez, F. Bibeau, and S. Thezenas p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis Br J Cancer 92 2005 2114 2121 (Pubitemid 40966245)
55. L.C. Lin, H.H. Lee, and W.S. Hwang p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy Surg Oncol 15 2006 211 216
56. I.J. Kim, S.B. Lim, and H.C. Kang Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer Dis Colon Rectum 50 2007 1342 1353 (Pubitemid 47472394)
57. H.B. Neuman, E.B. Elkin, and J.G. Guillem Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: A decision analysis Dis Colon Rectum 52 2009 863 871
58. I. Zlobec, R. Steele, N. Nigam, and C.C. Compton A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods Clin Cancer Res 11 2005 5440 5443 (Pubitemid 41060819)
59. R. Berardi, G. Mantello, and M. Scartozzi Locally advanced rectal cancer patients receiving radio-chemotherapy: A novel clinical-pathologic score correlates with global outcome Int J Radiat Oncol Biol Phys 75 2009 1437 1443
60. B.D. O'Neill, G. Brown, R.J. Heald, D. Cunningham, and D.M. Tait Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer Lancet Oncol 8 2007 625 633 (Pubitemid 47008889)